Logo image of HBI

HANESBRANDS INC (HBI) Stock Fundamental Analysis

NYSE:HBI - New York Stock Exchange, Inc. - US4103451021 - Common Stock

8.33  +0.04 (+0.48%)

After market: 8.33 0 (0%)

Fundamental Rating

3

Overall HBI gets a fundamental rating of 3 out of 10. We evaluated HBI against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of HBI have multiple concerns. HBI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year HBI was profitable.
HBI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HBI reported negative net income in multiple years.
HBI had a positive operating cash flow in 4 of the past 5 years.
HBI Yearly Net Income VS EBIT VS OCF VS FCFHBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of -4.20%, HBI is doing worse than 67.35% of the companies in the same industry.
HBI has a worse Return On Equity (-153.75%) than 89.80% of its industry peers.
The Return On Invested Capital of HBI (8.40%) is better than 65.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HBI is in line with the industry average of 11.39%.
Industry RankSector Rank
ROA -4.2%
ROE -153.75%
ROIC 8.4%
ROA(3y)-0.39%
ROA(5y)1.2%
ROE(3y)-8.39%
ROE(5y)2.82%
ROIC(3y)10.94%
ROIC(5y)11.34%
HBI Yearly ROA, ROE, ROICHBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

1.3 Margins

With a decent Operating Margin value of 10.31%, HBI is doing good in the industry, outperforming 77.55% of the companies in the same industry.
HBI's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 39.73%, HBI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
HBI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.31%
PM (TTM) N/A
GM 39.73%
OM growth 3Y-17.27%
OM growth 5Y-12.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2%
GM growth 5Y-2.46%
HBI Yearly Profit, Operating, Gross MarginsHBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

HBI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for HBI has been increased compared to 1 year ago.
Compared to 5 years ago, HBI has less shares outstanding
The debt/assets ratio for HBI has been reduced compared to a year ago.
HBI Yearly Shares OutstandingHBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
HBI Yearly Total Debt VS Total AssetsHBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

HBI has an Altman-Z score of 1.54. This is a bad value and indicates that HBI is not financially healthy and even has some risk of bankruptcy.
HBI has a Altman-Z score of 1.54. This is in the lower half of the industry: HBI underperforms 79.59% of its industry peers.
HBI has a debt to FCF ratio of 7.59. This is a slightly negative value and a sign of low solvency as HBI would need 7.59 years to pay back of all of its debts.
With a Debt to FCF ratio value of 7.59, HBI is not doing good in the industry: 63.27% of the companies in the same industry are doing better.
A Debt/Equity ratio of 21.50 is on the high side and indicates that HBI has dependencies on debt financing.
With a Debt to Equity ratio value of 21.50, HBI is not doing good in the industry: 93.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 21.5
Debt/FCF 7.59
Altman-Z 1.54
ROIC/WACC1.03
WACC8.15%
HBI Yearly LT Debt VS Equity VS FCFHBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

HBI has a Current Ratio of 1.49. This is a normal value and indicates that HBI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.49, HBI is not doing good in the industry: 73.47% of the companies in the same industry are doing better.
HBI has a Quick Ratio of 1.49. This is a bad value and indicates that HBI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.90, HBI is doing worse than 69.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.9
HBI Yearly Current Assets VS Current LiabilitesHBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 210.00% over the past year.
Measured over the past years, HBI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -49.01% on average per year.
The Revenue for HBI has decreased by -31.06% in the past year. This is quite bad
Measured over the past years, HBI shows a decrease in Revenue. The Revenue has been decreasing by -3.69% on average per year.
EPS 1Y (TTM)210%
EPS 3Y-65.41%
EPS 5Y-49.01%
EPS Q2Q%50%
Revenue 1Y (TTM)-31.06%
Revenue growth 3Y-2.74%
Revenue growth 5Y-3.69%
Sales Q2Q%-37.99%

3.2 Future

Based on estimates for the next years, HBI will show a very strong growth in Earnings Per Share. The EPS will grow by 73.35% on average per year.
The Revenue is expected to decrease by -6.82% on average over the next years.
EPS Next Y564.68%
EPS Next 2Y214.24%
EPS Next 3Y129.3%
EPS Next 5Y73.35%
Revenue Next Year-36.68%
Revenue Next 2Y-19.82%
Revenue Next 3Y-13.28%
Revenue Next 5Y-6.82%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HBI Yearly Revenue VS EstimatesHBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
HBI Yearly EPS VS EstimatesHBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.87, HBI can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as HBI.
When comparing the Price/Earnings ratio of HBI to the average of the S&P500 Index (28.29), we can say HBI is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 14.06, the valuation of HBI can be described as correct.
HBI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HBI is cheaper than 75.51% of the companies in the same industry.
HBI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.87
Fwd PE 14.06
HBI Price Earnings VS Forward Price EarningsHBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HBI is valued a bit cheaper than 65.31% of the companies in the same industry.
85.71% of the companies in the same industry are more expensive than HBI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.82
EV/EBITDA 11.38
HBI Per share dataHBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

HBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HBI's earnings are expected to grow with 129.30% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y214.24%
EPS Next 3Y129.3%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HBI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HANESBRANDS INC

NYSE:HBI (1/21/2025, 8:05:02 PM)

After market: 8.33 0 (0%)

8.33

+0.04 (+0.48%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-06 2025-02-06/amc
Inst Owners92.9%
Inst Owner Change2.34%
Ins Owners1.16%
Ins Owner Change0.94%
Market Cap2.94B
Analysts50.77
Price Target6.97 (-16.33%)
Short Float %12.6%
Short Ratio7.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.95%
Min EPS beat(2)24.38%
Max EPS beat(2)55.51%
EPS beat(4)3
Avg EPS beat(4)20.98%
Min EPS beat(4)-66.63%
Max EPS beat(4)70.66%
EPS beat(8)5
Avg EPS beat(8)17.32%
EPS beat(12)7
Avg EPS beat(12)12.69%
EPS beat(16)11
Avg EPS beat(16)16.43%
Revenue beat(2)0
Avg Revenue beat(2)-17.96%
Min Revenue beat(2)-27.34%
Max Revenue beat(2)-8.58%
Revenue beat(4)0
Avg Revenue beat(4)-11.25%
Min Revenue beat(4)-27.34%
Max Revenue beat(4)-3.41%
Revenue beat(8)1
Avg Revenue beat(8)-6.19%
Revenue beat(12)2
Avg Revenue beat(12)-5.28%
Revenue beat(16)4
Avg Revenue beat(16)-3.4%
PT rev (1m)0%
PT rev (3m)32.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.19%
EPS NY rev (1m)0%
EPS NY rev (3m)14.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-27.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 26.87
Fwd PE 14.06
P/S 0.73
P/FCF 6.82
P/OCF 6.23
P/B 19.66
P/tB N/A
EV/EBITDA 11.38
EPS(TTM)0.31
EY3.72%
EPS(NY)0.59
Fwd EY7.11%
FCF(TTM)1.22
FCFY14.67%
OCF(TTM)1.34
OCFY16.05%
SpS11.37
BVpS0.42
TBVpS-4.18
PEG (NY)0.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.2%
ROE -153.75%
ROCE 10.63%
ROIC 8.4%
ROICexc 9.14%
ROICexgc 16.77%
OM 10.31%
PM (TTM) N/A
GM 39.73%
FCFM 10.75%
ROA(3y)-0.39%
ROA(5y)1.2%
ROE(3y)-8.39%
ROE(5y)2.82%
ROIC(3y)10.94%
ROIC(5y)11.34%
ROICexc(3y)11.91%
ROICexc(5y)12.51%
ROICexgc(3y)26.81%
ROICexgc(5y)27.34%
ROCE(3y)13.85%
ROCE(5y)14.36%
ROICexcg growth 3Y-11.69%
ROICexcg growth 5Y-13.2%
ROICexc growth 3Y-15.44%
ROICexc growth 5Y-12.84%
OM growth 3Y-17.27%
OM growth 5Y-12.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2%
GM growth 5Y-2.46%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 21.5
Debt/FCF 7.59
Debt/EBITDA 6.22
Cap/Depr 39.12%
Cap/Sales 1.01%
Interest Coverage 250
Cash Conversion 91.24%
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 0.9
Altman-Z 1.54
F-Score4
WACC8.15%
ROIC/WACC1.03
Cap/Depr(3y)101.66%
Cap/Depr(5y)84.55%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)210%
EPS 3Y-65.41%
EPS 5Y-49.01%
EPS Q2Q%50%
EPS Next Y564.68%
EPS Next 2Y214.24%
EPS Next 3Y129.3%
EPS Next 5Y73.35%
Revenue 1Y (TTM)-31.06%
Revenue growth 3Y-2.74%
Revenue growth 5Y-3.69%
Sales Q2Q%-37.99%
Revenue Next Year-36.68%
Revenue Next 2Y-19.82%
Revenue Next 3Y-13.28%
Revenue Next 5Y-6.82%
EBIT growth 1Y9.73%
EBIT growth 3Y-19.54%
EBIT growth 5Y-15.59%
EBIT Next Year23.39%
EBIT Next 3Y11.22%
EBIT Next 5Y10.83%
FCF growth 1Y173.81%
FCF growth 3Y9.45%
FCF growth 5Y-1.46%
OCF growth 1Y219.1%
OCF growth 3Y7.79%
OCF growth 5Y-2.68%